Abstract
Summary: Dabigatran (Pradaxa) is a member of the relatively new class of antithrombotic drugs known as direct thrombin inhibitors (DTIs). It may supplant warfarin (Coumadin) in a number of applications as it may produce a more predictable, potent, and immediate anticoagulant effect, with fewer significant side effects and interactions, and requires less monitoring.
ABBREVIATIONS:
- aPTT
- activated partial thromboplastin time
- ECT
- Ecarin clotting time
- INR
- international normalized ratio
- pGP
- P-glycoprotein
- TT
- thrombin clotting time
- © 2012 by American Journal of Neuroradiology
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.